These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9536878

  • 1. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.
    Baudouin C, de Lunardo C.
    Br J Ophthalmol; 1998 Jan; 82(1):39-42. PubMed ID: 9536878
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride.
    Ishibashi T, Yokoi N, Kinoshita S.
    J Glaucoma; 2003 Dec; 12(6):486-90. PubMed ID: 14646684
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
    Martone G, Frezzotti P, Tosi GM, Traversi C, Mittica V, Malandrini A, Pichierri P, Balestrazzi A, Motolese PA, Motolese I, Motolese E.
    Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Influence on ocular surface and intraocular pressure of switching from preservative-containing to preservative-free carteolol hydrochloride ophthalmic solution].
    Chikama T, Araie M, Nishida T.
    Nippon Ganka Gakkai Zasshi; 2013 May; 117(5):419-26. PubMed ID: 23855234
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Time course of changes in ocular aberrations after instillation of carteolol long-acting solution and timolol gel-forming solution.
    Hiraoka T, Daito M, Okamoto F, Kiuchi T, Oshika T.
    J Ocul Pharmacol Ther; 2011 Apr; 27(2):179-85. PubMed ID: 21314439
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of benzalkonium chloride on the blood-aqueous and blood-retinal barriers of pseudophakic eyes.
    Abe RY, Zacchia RS, Santana PR, Costa VP.
    J Ocul Pharmacol Ther; 2014 Jun; 30(5):413-8. PubMed ID: 24660827
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma.
    Frezzotti P, Fogagnolo P, Haka G, Motolese I, Iester M, Bagaglia SA, Mittica P, Menicacci C, Rossetti L, Motolese E.
    Acta Ophthalmol; 2014 Mar; 92(2):e133-40. PubMed ID: 24020826
    [Abstract] [Full Text] [Related]

  • 20. [Effect of 8-hydroxycarteolol in normal human eyes].
    Kato Y, Sasaki T, Tsukahara S.
    Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):899-903. PubMed ID: 1354411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.